Background. Clostridium difficile infection (CDI) is one of the leading healthcareassociated infections in the United States. Antimicrobial pressure has been linked to increased incidence, severity and recurrences of CDI. As the initial step for development of a system-wide antimicrobial stewardship program for a large health system, we evaluated the relationship between antimicrobial use and hospital onset (HO) CDI standard infection ratio (SIR).
Methods. CDI SIRs were compared to the use of specific classes of penicillin, cephalosporin, carbapenem, quinolone, clindamycin, tigecycline, and total antimicrobials (defined daily dose/1,000 patient days) among 54 hospitals in one health system for the year 2013. Antimicrobial use and HO CDI SIR were compared factoring yearly patient days (≤25,000; 25,001-50,000; 50,001-75,000; >75,001) categories.
Results. The highest antimicrobial use per 1,000 patient-days was in groups with <25,000 patient days per year, (1177/1,000 patient-days). In addition, these hospitals represented the highest use of 3 rd generation cephalosporins, extended spectrum penicillins, and quinolones (Table) . However, HO CDI SIR did not correlate with increased antimicrobial use, and was associated with hospitals with patient-days >50,000 per year. Conclusion. Hospitals with lower patient days had the highest use of antimicrobial agents, and represent an important opportunity to target the antimicrobial stewardship efforts. On the other hand, CDI SIR may not be a good surrogate to evaluate their antimicrobial stewardship outcomes.
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